(Q24314425)

GOA release 2020-03-11

heparin binding

1 reference

GOA release 2020-03-11

1 reference

1 reference

Mélanie Héroult

0 references

Isabelle Bernard-Pierrot

0 references

Jean Delbé

0 references

Yamina Hamma-Kourbali

0 references

Panagiotis Katsoris

0 references

Denis Barritault

0 references

Evangelia Papadimitriou

0 references

Jean Plouet

0 references

José Courty

Dominant negative effectors of heparin affin regulatory peptide (HARP) angiogenic and transforming activities

0 references

language of work or name

English

0 references

publication date

4 March 2004

0 references

0 references

0 references

0 references

1745-53

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

The modular architecture of a new family of growth regulators related to connective tissue growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Endogenous angiogenesis inhibitors and their therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Transplacental carcinogenesis by stilbestrol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Heparin-binding growth-associated molecule contains two heparin-binding beta -sheet domains that are homologous to the thrombospondin type I repeat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Mitogenic andIn VitroAngiogenic Activity of Human Recombinant Heparin Affin Regulatory Peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Cellular distribution of the angiogenic factor heparin affin regulatory peptide (HARP) mRNA and protein in the human mammary gland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Upregulation of the angiogenic factor heparin affin regulatory peptide by progesterone in rat uterus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

41 LIGAND: A computerized analysis of ligand binding data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Endothelial cell proliferation induced by HARP: implication of N or C terminal peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Evidence that platelets promote tube formation by endothelial cells on matrigel.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Refolding and characterization of human recombinant heparin-binding neurite-promoting factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Angiogenesis: new insights and therapeutic potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Involvement of heparin affin regulatory peptide in human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206879

7 January 2021